A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor
Medical Device News Magazine is committed to delivering high‑quality, in‑depth medical device news and biotechnology updates that include expert bylines. Our coverage offers a comprehensive view of the trends, innovations, and breakthroughs shaping the future of medical technology.
We also strive to provide a distinctive perspective on the rapidly evolving healthcare landscape. By staying connected with our reporting, you gain access to exclusive insights on industry developments, emerging technologies, and global regulatory changes that influence the medical device sector. At the same time, you join a vibrant community of professionals, innovators, and thought leaders dedicated to advancing healthcare through cutting‑edge solutions.
We invite you to explore our wide range of content—from the latest product announcements to detailed analyses of industry trends. And if our mission aligns with your goals, we offer opportunities for advertising and collaboration, helping you connect with a highly engaged audience of medical technology professionals.
Definition medical devices.
New platform enables PBMs, TPAs, and healthcare organizations to connect pricing, patient onboarding, compliance documentation, and shipment tracking directly into existing systems
By delivering a seamless, automated solution, Halo340B eliminates the complexities of program compliance while uncovering missed opportunities to significantly increase revenue for covered entities
Leading concierge practice Atelier Health, led by physicians affiliated with Cedars-Sinai, will now offer HeartBeam to its patients. Opens up flagship sites across New York, Dallas, South Florida and Southern California, supporting scalable expansion of HeartBeam technology in preventive cardiology.
Alex Joseph will take on the role of Chief Executive Officer, succeeding Iwan van Vijfeijken.
Vertex Pulmonary Embolectomy System demonstrated significant right heart recovery, low adverse event rates, and reproducible performance across high-severity PE patients
Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes
The technology is customized to each patient’s breast and tumor via 3D printing
“By integrating Oxford Nanopore’s direct RNA sequencing into Lonza’s QC environment, we are enabling a more comprehensive and scalable approach to mRNA quality control,” said Francis Van Parys, CEO, Oxford Nanopore Technologies
Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases
This evolution formalizes Mopec Group's commitment to developing integrated, technology-driven solutions that enhance how pathology laboratories document, manage, and move through the diagnostic workflow
Acquisition will enhance Medtronic’s Neuromodulation portfolio with temporary peripheral nerve stimulation (PNS) technology, enabling earlier intervention for chronic pain sufferers
Under the terms of the agreement, Lilly will acquire Kelonia, and Kelonia shareholders will receive up to $7.00 billion in cash, inclusive of an upfront payment of $3.25 billion, and subsequent payments upon achievement of certain clinical, regulatory and commercial milestones
CathWorks FFRangio® System employs drug-free, wire-free technology for comprehensive physiological assessmen
This strategic move unites Fertio’s 20+ years of global expertise with Cascade’s innovative early donor disclosure program, advancing fertility care and family-building options for U.S. parents
Advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery technologies
The funding will accelerate Earendil Labs’ AI-driven R&D platform, expand its interdisciplinary teams, and advance a growing pipeline of antibody and biologics programs, with the goal of delivering first-in-class and best-in-class therapies for patients with serious diseases.
Financing co-led by Taiho Ventures and Arkin Bio Capital with significant participation from other new and existing investors
The financing significantly strengthens the company’s capital position as it expands U.S. commercial infrastructure and advances clinical evidence generation across its endovascular catheter platform.
Katherine Klyushnichenko
DiogeneAge, Inc. 1910 Thomes Avenue, Cheyenne, Wyoming 82001-3527, USA | kathy@diogeneage.com
While many regenerative treatments rely on injections administered in specialized clinics, his cream is designed to offer a non-invasive alternative
Pharmacovigilance has traditionally required organizations to balance the urgency of reporting with the rigor of accurately detecting adverse event and product complaints. AI has the potential to ease this burden by enabling earlier pre‑signal identification, automated detection, faster case processing and expanded surveillance across both structured and unstructured data
By Dinesh Kumar, Ph.D., Founder and CEO of Blend Health Technologies
The FDA determined the SPAXUS™ Stent to be substantially equivalent to legally marketed predicate devices, allowing for commercialization in the United States
The Procleix Plasmodium Assay aims to improve blood safety by detecting Plasmodium, a mosquito-borne parasite that causes malaria and is responsible for an estimated 282 million infections and 610,000 global deaths annually
Mehta brings 25+ years of healthcare Revenue Cycle Management experience with a proven track record of scaling complex operations, driving financial performance, implementing advanced technologies, and building high-performing teams
As Chief Medical Officer, Dr. Steinhubl will help drive Eko’s clinical strategy, research initiatives, and external scientific collaborations, further strengthening the evidence base and accelerating AI adoption across health systems worldwide.
Brown brings more than 20 years of experience in mitochondrial research and scientific team leadership.
Dr. Lee is a renowned talent, in the fields of both neurosurgery and finance
Dr. Michalis Papadakis, CEO and Co-Founder of Brainomix said: “We are excited to expand our strategic partnership with Boehringer Ingelheim, a recognized leader and innovator in this field, with whom we share a firm commitment to improving outcomes for people living with pulmonary fibrosis.
Olympus Corporation, a global medical technology company committed to making people’s lives healthier, safer, and more fulfilling, announced today it has received FDA 510(k) clearance
Dan Xu, Business Leader of CT at Philips. “With the Rembra platform, we are redefining what clinicians can expect from CT, combining speed, scalability, and precision to expand access to high-quality imaging while supporting confident diagnosis and highly accurate treatment planning.”
The world’s first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications
SeleCT Screening automatically reviews existing chest computed tomography (CT) scans to help identify patients who would benefit from bronchoscopic lung volume reduction (BLVR). BLVR with endobronchial valves such as the Spiration Valve System may improve lung function by allowing airflow to be redirected from hyperinflated portions of the lung to healthier portions
Chief People Officer, Nikki Romence, has been named one of Becker’s Hospital Review’s “140 Hospital and Health System CHROs and Chief People Officers to Know” for 2026
Located in southeast Jacksonville near Baptist Medical Center Clay, the multispecialty ASC supports procedures in orthopedics, urology, otolaryngology, pain management, and general surgery. With 15 physician partners committed to the center, the partnership is evaluating expansion opportunities to meet growing demand.
The clinic is currently conducting research into single-fraction treatment, where therapy is delivered in one session (while traditional radiotherapy requires 20–40 treatment sessions)
Industry leaders from across the health ecosystem, including Clue, Ema EQ, Thrive Global, Oura, and Willow, will set the first clinically rigorous, transparent standards for AI in women’s health
New Industry Research Shows Record 11,458 Hospitals and Surgical Centers in 18 Countries Used Reprocessed Devices to Reduce Costs, Emissions Last Year
As the national voice of optometry, CAO remains committed to using Vision Health Month to raise awareness about the importance of regular, comprehensive eye exams
For the study, 564 U.S. Special Operations Forces personnel (mean age 43 years, 563 men) were evaluated in the Comprehensive Brain Health and Trauma Program.
Introduction Although there has always been health misinformation, its current scope, velocity, and impact are unmatched in contemporary times. Health misinformation is one of the
As technology continues to evolve, this trend will likely become even more pronounced. Patients will have access to more detailed information, better tools for comparison, and clearer insights into the care they’re considering.
The combination of zygomatic implants and digital workflow integration has transformed the landscape of full-arch rehabilitation for individuals with severe maxillary atrophy
Transitioning to a well-built cloud setup does much more than upgrade your software. It completely transforms your daily IT challenges into seamless operational opportunities
